Israeli medical cannabis inhaler receives approval to sell in Canada | JNS

Israeli pharmaceutical tech company Syqe Medical has received approval from Canadian health authorities to sell its metered medical cannabis inhaler in Canada announced On Wednesday.

The Syqe Inhaler – the first pharmaceutical grade medical cannabis delivery device – releases a controlled amount of cannabinoids with each inhalation to ensure that medical marijuana patients get the right dose.

The technology used in the handheld portable device has been researched and developed for 10 years, including testing in a series of research trials, said Michael Milloy, general manager of Syqe Medical in Canada.

The inhaler will be available to patients in Canada with medical approval through Syqe Medical Canada in partnership with a Canadian approved manufacturer.

Peter Blecher, Medical Director of Canada’s CPM Centers for Pain Management, said: “Cannabis for medical purposes has been hampered by unreliable dosing methods such as smoking, and doctors have been looking for a suitable alternative. Finding the dose that gives a consistent result has been problematic for health professionals. With its precision and constant microdosing capability, the Syqe inhaler can meet this unmet need. “

The post Israeli medical cannabis inhaler receives approval for sale in Canada first appeared on JNS.org.